This study aims to optimize the SPE parameters for purification and preconcentration of EFV and LVG to enable optimum detection and quantification by LC-20 Prominence High-Performance Liquid Chromatography (HPLC) system.
E. P. Munzhelele +4 more
doaj +1 more source
Safety of efavirenz in the first trimester of pregnancy
Nathan Ford +2 more
openalex +2 more sources
48 week bone marker changes with Dolutegravir (DTG) plus Abacavir/Lamivudine (ABC/3TC) vs. Tenofovir/Emtricitabine/Efavirenz (EFV/TDF/FTC): the SINGLE trial [PDF]
Yazdan Yazdanpanah +9 more
openalex +1 more source
Efficacy and safety of a single‐tablet regimen containing tenofovir disoproxil fumarate 300 mg, lamivudine 300 mg and efavirenz 400 mg as a switch strategy in virologically suppressed HIV‐1‐infected subjects on nonnucleoside reverse transcriptase inhibitor‐containing first‐line antiretroviral therapy in Pune, India [PDF]
Ameet Dravid +9 more
openalex +1 more source
Biological effects of two antiretroviral tritherapy (stavudine-lamivudine-nevirapine and emitricitabine-tenofovir-efavirenz) in patients HIV positive in Abidjan (Côte d’Ivoire) [PDF]
Kouakou Koffi Tovi Wahon Marie Odile
openalex +1 more source
Effect of Efavirenz on the Pharmacokinetics of SHR6390 in Healthy Volunteers
Jin Wang, Chaoying Hu, Lan Zhang Department of Pharmacy, Phase I Clinical Trial Center, Xuanwu Hospital Capital Medical University, Beijing, People’s Republic of ChinaCorrespondence: Chaoying Hu; Lan Zhang, Email hucarol@126.com; xwzhanglan@126 ...
Hu C, Zhang L, Wang J
core
Efavirenz Intoxication Due to Slow Hepatic Metabolism
We describe a human immunodeficiency virus-positive woman who presented with severe psychosis while she was receiving therapy with efavirenz. Her plasma efavirenz level was excessively high.
Hasse, B. +3 more
core
Quantifying the risks and benefits of efavirenz use in HIV-infected women of childbearing age in the USA [PDF]
Heather Hsu +10 more
openalex +1 more source
Desenvolvimento e validação de metodologia para a certificação da pureza enantiomérica do Efavirenz
CECÍLIA SUMIE FUZITA WATANABE +6 more
openalex +2 more sources
Evaluation of cardiovascular biomarkers in a randomized trial of fosamprenavir/ritonavir vs. efavirenz with abacavir/lamivudine in underrepresented, antiretroviral-naïve, HIV-infected patients (SUPPORT): 96-week results [PDF]
for the SUPPORT Study Team +12 more
openalex +1 more source

